Search For "heterologous booster dose"
NTAGI holds meeting on Covovax inclusion as heterologous booster on CoWin
Updated : 3 years, 3 months ago IST
National Technical Advisory Group on Immunisation conducted a meeting on February 8 regarding the inclusion of Covid19 vaccine Covovax as a heterologous booster dose for adults on the CoWin portal to boost uptake of the doses, sources said on Thursday.
Read More
Bharat Biotech's intranasal heterologous booster dose likely to hit market
Updated : 3 years, 4 months ago IST
According to the company, the price of iNCOVACC will be Rs 900 for the private market and Rs 325 for supplies to the Government of India and State Governments.
Read More
NTAGI to discuss inclusion of Covovax in CoWIN portal as heterologous boos
Updated : 3 years, 4 months ago IST
The National Technical Advisory Group on Immunisation (NTAGI) is likely to meet soon to discuss inclusion of Covid vaccine Covovax on the CoWIN portal as a heterologous booster dose for adults to boost uptake of booster doses, said official sources.
Read More
DCGI recommends Covovax as heterologous booster dose
Updated : 3 years, 4 months ago IST
The Central drug regulatory authority Drugs Controller General of India (DCGI) has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for those who have already taken two doses of Covishield or Covaxin.
Read More
Bharat Biotech's nasal Covid vaccine to be priced at Rs 800 for private an
Updated : 3 years, 5 months ago IST
Bharat Biotech's nasal COVID-19 vaccine iNCOVACC, which was given approval as a booster dose, will be priced at Rs 800 plus GST in private hospitals..
Read More
Bharat Biotech's nasal Covid vaccine for adults gets Centre's nod, to be a
Updated : 3 years, 5 months ago IST
Bharat Biotech's nasal vaccine - iNCOVACC has been approved by the Government of India and will be used as a heterologous booster dose for those above 18 years of age
Read More
DCGI approves '5-arms intranasal hetrologous booster dose' for restricted
Updated : 3 years, 6 months ago IST
The Drugs Controller General of India (DCGI) has given approval to intranasal "Five Arms" booster dose for restricted use for COVID-19 patients, it is learnt.
Read More
DCGI's subject expert committee to hold discussion on 'Five Arms' intranas
Updated : 3 years, 6 months ago IST
DCGI has already given emergency use authorization (EUA) to BBIL for the intranasal vaccine. BBIL had in September this year applied for DCGI's approval for market authorization of its "Five Arms" intranasal heterologous booster dose, and it has now announced that iNCOVACC (BBV154) has re
Read More
CORBEVAX booster shot approved for 18 years and above jabbed with Covaxin,
Updated : 3 years, 9 months ago IST
New Delhi [India], August 10 (ANI): The Central government has approved Biological E's Corbevax for restricted use in an emergency as a heterologous booster dose, official sources confirmed on Wednesday.
Read More